MicroPort Endovascular MedTech Ltd (688016) — Cash Flow Reinvestment Rate
MicroPort Endovascular MedTech Ltd (688016) has a Cash Flow Reinvestment Rate of 1.84x as of September 2025, reinvesting CN¥86.03 Million (capex CN¥86.03 Million ) from operating cash flow of CN¥46.79 Million. See MicroPort Endovascular MedTech Ltd (688016) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
MicroPort Endovascular MedTech Ltd Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for MicroPort Endovascular MedTech Ltd across 10 annual periods. For the full cash flow conversion analysis, see 688016 cash flow conversion.
Annual Cash Flow Reinvestment Rate for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year capital reinvestment analysis for MicroPort Endovascular MedTech Ltd. See MicroPort Endovascular MedTech Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.68x | CN¥387.06 Million | CN¥573.06 Million | CN¥303.03 Million | ▼ -9.9% |
| 2024 | 0.75x | CN¥280.12 Million | CN¥373.60 Million | CN¥212.65 Million | ▼ -54.3% |
| 2023 | 1.64x | CN¥937.55 Million | CN¥571.22 Million | CN¥190.26 Million | ▼ -25.3% |
| 2022 | 2.20x | CN¥733.78 Million | CN¥333.76 Million | CN¥293.98 Million | ▲ +302.1% |
| 2021 | 0.55x | CN¥164.15 Million | CN¥300.25 Million | CN¥89.58 Million | ▲ +240.6% |
| 2020 | 0.16x | CN¥34.90 Million | CN¥217.44 Million | CN¥26.22 Million | ▼ -28.8% |
| 2019 | 0.23x | CN¥32.30 Million | CN¥143.20 Million | CN¥21.24 Million | ▼ -51.5% |
| 2018 | 0.47x | CN¥49.70 Million | CN¥106.85 Million | CN¥24.90 Million | ▲ +13.2% |
| 2017 | 0.41x | CN¥28.49 Million | CN¥69.36 Million | CN¥28.23 Million | ▼ -80.6% |
| 2016 | 2.12x | CN¥63.77 Million | CN¥30.13 Million | CN¥31.81 Million | — |